ModifiedBlue Cross Blue Shield - TennesseePolicy N/A

Cardiovascular Disease Risk Assessment (laboratory testing)

Defines coverage criteria for laboratory tests and biomarker panels used for cardiovascular disease (CVD) risk assessment in adults, including lipid panels, apoB, Lp(a), hs-CRP, and other biomarkers; applies to BlueCross BlueShield of Tennessee determinations.

Policy Summary

PayerBlue Cross Blue Shield - Tennessee

PolicyCardiovascular Disease Risk Assessment (laboratory testing)

Policy CodePolicy N/A

Change TypeCoverage clarification and coding update

Effective Date

Next Review Date

Key ActionDocument patient age and clinical indication, record confirmatory hs-CRP timing when used, and use updated CPT codes (including 0541U/0308U) where applicable to support coverage.

SourceLink

POLICY UPDATE CHANGES

Clarified that Lp(a) measurement meets coverage criteria once per lifetime and should occur when the individual is 18 years of age or older.

Clarified hs-CRP screening frequency and confirmation: initial test, a confirmatory test no sooner than two weeks after an abnormal initial result, and annual measurement thereafter if confirmed elevated.

Background, guidelines and evidence references were updated after literature review.

Lp(a) screening is covered once per lifetime and should occur when the individual is 18 years of age or older.

hs-CRP screening now defined as up to two measurements for initial evaluation with confirmatory testing at least two weeks later, and annual testing thereafter if confirmed elevated.

Policy defines which CRP tests do NOT meet coverage criteria: hs-CRP for cardiovascular risk assessments not described and conventional CRP for CVD risk assessment are not covered.

Added CPT code 0541U and revised laboratory name for CPT code 0308U effective 2025-04-01.

Updated background, guidelines, recommendations, and references after literature review.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.